Disparities Exist in Wait-Listing for Pediatric Kidney Transplants
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 1, 2024 -- Disparities in timely wait-listing among pediatric kidney transplant candidates expose some patients to greater harms from dialysis, according to a study published online Aug. 1 in Pediatrics.
Lindsey M. Maclay, from the Columbia University Vagelos College of Physicians and Surgeons in New York City, and colleagues assessed disparities in timely access to transplant wait-listing among 4,506 children (ages 3 to 17 years) added to the U.S. kidney transplant wait list in 2015 to 2019.
The researchers found that female sex, Hispanic ethnicity, Black race, and public insurance were associated with a lower adjusted relative risk for preemptive wait-listing (that is, wait-list addition before receiving dialysis), which was not associated with time from wait-list activation to transplantation (adjusted hazard ratio 0.94; 95 percent confidence interval, 0.87 to 1.02). Nearly two-thirds of transplant recipients wait-listed preemptively had no pretransplant dialysis (68 percent), whereas recipients listed nonpreemptively had a median 1.6 years of dialysis at transplant. For 415 candidates initiating dialysis as children but wait-listed as adults, the transplant rate was lower compared with nonpreemptive pediatric candidates after wait-list activation (adjusted hazard ratio, 0.54; 95 percent confidence interval, 0.44 to 0.66).
"Disparities in timely wait-listing are associated with differences in pretransplant dialysis exposure despite no difference in time to transplant after wait-list activation," the authors write. "Young adults who experience delays may miss pediatric prioritization, highlighting an area for policy intervention."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-02 01:15
Read more
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- E. Coli Spurs Nationwide Organic Carrots Recall
- Recreational Cannabis Legalization Tied to Higher Prenatal Use
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- Depression Rates on the Rise for Sexual, Gender Minority College Students
- Antiviral Treatment Underutilized for Children, Teens With Flu
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions